Profilo
Andrea Ballagi is currently Director at Bio-Works Technologies AB since 2026 and Global Head-Market Development at Olink Proteomics AB. Former positions include Director-Commercial Operations at Moleculink AB in 2014 and General Manager at IDEXX Laboratories, Inc. Education includes an MBA from the University of Uppsala.
Posizioni attive di Andrea Ballagi
| Società | Posizione | Inizio |
|---|---|---|
| BIO-WORKS TECHNOLOGIES AB | Direttore/Membro del Consiglio | 04/06/2026 |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Provides commercial physical and biological research and development | Corporate Officer/Principal | - |
Precedenti posizioni note di Andrea Ballagi
| Società | Posizione | Fine |
|---|---|---|
| IDEXX LABORATORIES, INC. | Corporate Officer/Principal | - |
Moleculink AB
Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Provides diagnostic products for life science research purposes | Direttore operativo | - |
Formazione di Andrea Ballagi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. Medical SpecialtiesHealth Technology Develops animal diagnostic, software and imaging & water treatment systems | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moleculink AB
Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Provides diagnostic products for life science research purposes | Electronic Technology |
Bio-Works Technologies AB
Bio-Works Technologies AB BiotechnologyHealth Technology Provides research and development within food production and life science | Health Technology |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Provides commercial physical and biological research and development | Commercial Services |
















